EbookBell.com

Most ebook files are in PDF format, so you can easily read them using various software such as Foxit Reader or directly on the Google Chrome browser.
Some ebook files are released by publishers in other formats such as .awz, .mobi, .epub, .fb2, etc. You may need to install specific software to read these formats on mobile/PC, such as Calibre.

Please read the tutorial at this link: https://ebookbell.com/faq

We offer FREE conversion to the popular formats you request; however, this may take some time. Therefore, right after payment, please email us, and we will try to provide the service as quickly as possible.

For some exceptional file formats or broken links (if any), please refrain from opening any disputes. Instead, email us first, and we will try to assist within a maximum of 6 hours.

EbookBell Team

Animal Cell Technology From Target To Market Proceedings Of The 17th Esact Meeting Tylosand Sweden June 1014 2001 1st Edition Arne Burzlaff

Name: Animal Cell Technology From Target To Market Proceedings Of The 17th Esact Meeting Tylosand Sweden June 1014 2001 1st Edition Arne Burzlaff
SKU: BELL-4284826
Price: 31.00 USD
Availability: InStock
Rating: 4.25 (18 reviews)

SKU: BELL-4284826

Animal Cell Technology From Target To Market Proceedings Of The 17th Esact Meeting Tylosand Sweden June 1014 2001 1st Edition Arne Burzlaff

$ 31.00 ~~$ 45.00~~ (-31%)

4.3

18 reviews

Animal Cell Technology From Target To Market Proceedings Of The 17th Esact Meeting Tylosand Sweden June 1014 2001 1st Edition Arne Burzlaff instant download after payment.

Publisher: Springer Netherlands

File Extension: PDF

File size: 17.55 MB

Pages: 595

Author: Arne Burzlaff, Cornelia Kasper, Mathias Christmann, Ulhas Bhatt, Markus Kalesse (auth.), Dr Elisabeth Lindner-Olsson, Ms Nathalie Chatzissavidou, Dr Elke Lüllau (eds.)

ISBN: 9789401003698, 9789401038973, 9401003696, 940103897X

Language: English

Year: 2001

Edition: 1

Product desciption

Animal Cell Technology From Target To Market Proceedings Of The 17th Esact Meeting Tylosand Sweden June 1014 2001 1st Edition Arne Burzlaff by Arne Burzlaff, Cornelia Kasper, Mathias Christmann, Ulhas Bhatt, Markus Kalesse (auth.), Dr Elisabeth Lindner-olsson, Ms Nathalie Chatzissavidou, Dr Elke Lüllau (eds.) 9789401003698, 9789401038973, 9401003696, 940103897X instant download after payment.

This book is the lasting product, a resource of up-to-date information in the scientific literature for the field of animal cell technology, as it was presented during a pleasant and stimulating meeting in Tylosand, Sweden, in June 2001. The title of the meeting, FromTarget to Market, indicates the usefulness of Animal Cell Technology during all steps in the pharmaceutical development process. Following the biotech products reaching the market, it shows an upward trend in the contribution of biotech products to total New Molecular Entity output in the nineties, which continued until 1996 when biotech represented 25% of the annual output. Since then the proportion has been decreasing.
A perceived hurdle from a market perspective is that a protein per definition is biodegradable and thus requires intravenous, or for some drugs subcutaneous administration. New promising administration technologies such as pulmonary delivery were highlighted at this meeting.
The emphasis on project selection prior to entry in the development phase has triggered a portfolio management using more extensive preclinical data before a development decision is taken. Animal cells have become a very important tool in the drug discovery process. The next generation of products will evolve from applications such as gene therapy, novel vaccines, cell therapy, and gene regulation.
Animal cell technology has a major role to play in the post-sequence era.